Pancreatoduodenectomy With Mesopancreas Dissection.A Prospective Study Comparing Artery-first Approach Versus Standard Approach
NCT03224832 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2017-08-10
Summary
The definitions for R0 and R1 margin status after resection for pancreatic cancer are controversial.Various studies showed the rate of noncurative resections of 15- 35 % but with modified pathological examination (R1/R2) revealed the rate of R1 resection was higher ranging from 76-85 % .
Verbeke CS etal.
* Whether this discrepancy was caused by incomplete lymphnode dissection, perineural dissection and improper pathological examination was not yet known.
* Perineural invasion was detected in 77 % of specimens of resected pancreatic cancers.
So the researchers emphasized the need of new surgical classification involving mesopancreas. It can be considered as an anatomical space bounded anteriorly by the the posterior surface of the pancreatic neck, posteriorly by the pancreaticoduodenal coalescence fascia, medially by the mesenteric vessels with -nerves, lymphatics and vessels as its contents.
Conditions
- Periampullary Carcinoma Resectable
Interventions
- PROCEDURE
-
Artery-first Approach
Dissection at the origin of the superior mesenteric artery and the celiac trunk all along their right side of the vessels. -En bloc resection of the primary tumor and regional lymph nodes through complete excision of the mesopancreatic plane, utilizing the artery-first approach. * The mesopancreatic plane consists of the pancreas head, the uncinate process of the pancreas, and the meso-pancreatoduodenum. All the tissues that lay in this triangular space (SMA down, CT up, and SMV-PV anterior) is cleared. Then the investigators continue the dissection along the right then anterior surface of the SMV and PV until reaching the dissected posterior surface the neck of the pancreas . Last step is the division of the neck of the pancreas. After the specimen is removed and before it is sent to the pathology we put mark on each boundary of the specimen one towards SMA, another towards PV/SMV area and the last towards the posterior surface of the mesopancreas.
- PROCEDURE
-
Standard Approach
In standard approach after kocharization of the duodenum the investigators start to asses the tunnel under the neck of the pancreas whether tumor infilterating PV/SMV axis and if not we cut the neck of pancreas early in the procedure then we continue to dissect the uncinate process and control pancreatoduodenal vessels and draining lymph nodes and LNS around portal vein and up to hepatic artery and we will add to the standard procedure the previously defined mesopancreatic triangle dissection which lies between SMA caudal, Coeliac artery cranial and PV/SMV axis anterior and the specimen will be marked and sent as previous to pathology.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-31
- Primary Completion
- 2019-07-01
- Completion
- 2020-01-01
Countries
- Egypt
Study Locations
More Related Trials
-
Reoperation After Pancreaticoduodenectomy
NCT04387903 ·Status: UNKNOWN
-
Pancreatic Surgery in Elderly Patients
NCT04893408 ·Status: COMPLETED
-
Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy
NCT06135649 ·Status: RECRUITING
-
Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy
NCT05489458 ·Status: UNKNOWN
-
Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer
NCT07232810 ·Status: RECRUITING ·Phase: NA
-
Hepatic Resection for Metastatic Pancreatic Cancer
NCT02892305 ·Status: ACTIVE_NOT_RECRUITING
-
Margin Status After Pancreaticoduodenectomy for Cancer
NCT03267966 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas
NCT00918853 ·Status: COMPLETED ·Phase: NA
-
Cohort Study on Nutritional, Metabolic, and Volumetric Assessment After Pancreaticoduodenectomy
NCT07159672 ·Status: COMPLETED
-
A New Anatomical Classification of Portal Vein Location of Pancreas Tumors
NCT04416685 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer
NCT02479984 ·Status: UNKNOWN ·Phase: NA
-
Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma
NCT05134961 ·Status: COMPLETED
-
D2 Versus D1 Gastrectomy of Operable Gastric Cancer
NCT04429841 ·Status: COMPLETED
-
Efficacy of the Triangle Operation on Clinical Outcomes in Patients With Pancreatic Cancer
NCT05703139 ·Status: RECRUITING
-
Surgery for Liver Metastases From PDAC
NCT05271110 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
According CTC to Compare the Influences of Different Methods to Remove the PDAC
NCT02451384 ·Status: UNKNOWN ·Phase: NA
-
Isolation Procedure vs. Conventional Procedure During Distal Pancreatectosplenectomy for Pancreatic Cancer
NCT04600063 ·Status: UNKNOWN ·Phase: NA
-
Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma
NCT04340440 ·Status: COMPLETED ·Phase: NA
-
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer
NCT02333721 ·Status: UNKNOWN ·Phase: NA
-
Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer
NCT03792932 ·Status: UNKNOWN ·Phase: NA
-
Resection for Multiple Hepatocellular Carcinomas (HCC)
NCT01387061 ·Status: COMPLETED ·Phase: NA
-
The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer
NCT01332773 ·Status: UNKNOWN ·Phase: PHASE3
-
RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma
NCT03320980 ·Status: COMPLETED
-
Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT05788029 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma
NCT00495924 ·Status: COMPLETED